Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus (Q45733325)

15 December 2017

title

Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus (English)

1 reference

15 December 2017

0 references

Höllsberg P

1 reference

15 December 2017

publication date

1 February 2002

1 reference

Scandinavian Journal of Immunology

15 December 2017

published in

1 reference

15 December 2017

1 reference

15 December 2017

1 reference

15 December 2017

page(s)

189-195

1 reference

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Mechanisms of MHC class I--restricted antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Modification of cysteine residues in vitro and in vivo affects the immunogenicity and antigenicity of major histocompatibility complex class I-restricted viral determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Characterization of two Epstein-Barr virus epitopes restricted by HLA-B7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

The response to H-2-different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Different MHC class I alleles compete for presentation of overlapping viral epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

MHC-linked LMP gene products specifically alter peptidase activities of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0300-9475.2001.01043.X

10.1046/J.0300-9475.2001.01043.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference